Skip to content
Menu

VEON Ltd. VEON

Full chart Compare
Set alert

Price alert · VEON

All alert types
75.30 USD -0.26 (-0.34%)

Regular-session close

75.06 -0.24 -0.32%

After hours · Nov 20, 4:00 PM ET

73.45 Day range 76.88
44.00 52-week range 89.00
YTD
+43.24%
1 year
+46.16%

Fundamental scorecard

11 of 25 checks passed on VEON’s reported financials

ValueGrowthProfitabilityHealthDividend

11of 25 checks passed

  • Value 2 of 5
  • Growth 4 of 5
  • Profitability 4 of 5
  • Financial health 1 of 5
  • Dividend 0 of 5

Statements to Jun 30, 2026.

Value 2 of 5

  • Failed:P/E below its own 5-year median P/E 9.7 against a 5-year median of 6.8.
  • Passed:P/E under 20 P/E 9.7: an earnings yield of 10.3%.
  • Failed:Price to sales below its own 5-year median Price to sales 1.2 against a 5-year median of 0.7.
  • Failed:Price to book below its own 5-year median Price to book 3.4 against a 5-year median of 2.6.
  • Passed:Free cash flow yield above 4% Free cash flow of 630M is 12.1% of the market value.

Growth 4 of 5

  • Passed:Revenue grew over the last year Revenue of 4.40B is +9.9% on the year before.
  • Failed:Revenue grew more than 5% a year over five years +4.8% a year from FY 2020 to FY 2025.
  • Passed:Earnings per share grew over the last year EPS 7.50 against 5.75 in the year before.
  • Passed:Earnings per share grew more than 5% a year over five years EPS -5.00 in FY 2020, 7.50 in FY 2025.
  • Passed:Analysts expect higher earnings per share over the next year The average forward estimate is +63.0% on the last 12 months.

Profitability 4 of 5

  • Passed:Profitable over the last year Net income of 532M over FY 2025.
  • Failed:Profitable in each of the last five fiscal years A profit in 3 of the last 5 fiscal years.
  • Passed:Return on equity above 15% Return on equity of 40.7%.
  • Passed:Net margin above its 5-year average Net margin of 12.1% against a 5-year average of -6.5%.
  • Passed:Free cash flow is at least 80% of net income Free cash flow of 630M is 118.4% of net income.

Financial health 1 of 5

  • Failed:Short-term assets cover short-term liabilities Short-term assets of 3.71B against short-term liabilities of 3.83B.
  • Failed:Short-term assets cover long-term liabilities Short-term assets of 3.71B against long-term liabilities of 4.52B.
  • Failed:Net debt under 40% of equity Net debt of 2.79B is 184.4% of equity.
  • Passed:Operating cash flow covers at least 20% of debt Operating cash flow of 1.35B is 23.1% of debt.
  • Failed:Operating profit covers interest at least 3 times Operating profit is 2.4 times the interest expense.

Dividend 0 of 5

  • Failed:Pays a dividend No dividend paid.
  • Failed:Yield above 1.5% No dividend paid.
  • Failed:Pays out under 75% of profit No dividend paid.
  • Failed:Covered by free cash flow No dividend paid.
  • Failed:Not cut in the last five fiscal years No dividend paid.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What VEON owns and owes, as of Jun 30, 2026

Short term and long term

Balance sheet · 10.3B of assets

Debt, equity and cash by year

Now: 2.79B of debt after cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

0.95 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 2
  • Return on Assets 2
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E 7.0×
P/S 0.8×
P/B 2.8×
P/FCF 6.0×
EV/EBITDA 3.3×
EV/Sales 1.6×
FCF Yield 16.7%

Profitability

Gross Margin 69.8%
Operating Margin 23.3%
Net Margin 12.1%
ROE 40.4%
ROIC 11.4%
ROA 5.9%

Growth (YoY)

Revenue 11.8%
Operating Income -6.0%
EPS (diluted) 30.9%
Free Cash Flow 20.6%

Financial Health

Current Ratio 0.9×
Quick Ratio 0.9×
Debt / Equity 3.8×
Net Debt / EBITDA 1.6×
Interest Coverage 1.9×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2025-12-31